Study of ITI-1284 brain effects in healthy volunteers
Treatments studied
This study tests how a new drug, ITI-1284, works in the brain using PET scans. It helps researchers understand how the drug binds to receptors and how safe it is in healthy people.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 55 years old.
- You have a body mass index (BMI) between 18 and 32, and weigh at least 110 pounds (50 kg).
- You are willing to stay in the hospital research unit for the whole inpatient period.
- You do not have any significant heart, liver, kidney, nerve, stomach, lung, hormone, blood, or immune disease, or a history of cancer.
- You do not have any metal implants, claustrophobia, or other reasons that would prevent you from having an MRI or PET/CT scan.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests how two experimental drugs, IN-M00007 and IN-R00007, move through the body and how safe they are. It is for healthy adults to gather basic information before testing in patients.
This trial tests the safety of a new drug called ISM4808 in healthy adults. It helps doctors see how the drug affects the body and if it causes any side effects before moving to larger studies.
This research tests a new, non-invasive method to stimulate deep brain areas using electrical fields applied to the scalp. The study aims to understand how safe and effective this approach is in healthy adults, which could eventually help treat neurological or psychiatric conditions.
This study tests a new method of stimulating deep brain areas without surgery, using special electrical currents. It aims to see if this method is safe and effective in healthy adults.
This study tests a new drug called BMS-986521 using a special brain scan (PET scan) to see how well it attaches to certain receptors in the brain. It is for healthy volunteers to help understand how the drug works.
This study tests a new radioactive dye called [18F]GATT-44 to see how well it can show a specific brain protein on a PET scan. It may help researchers better understand brain conditions in the future.
Hear when a new Healthy Volunteers trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.